Christophe Klein

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Jakob Nikolas Kather, N. Loménie, J. Pawlotsky, 2023, The Lancet. Oncology.

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

C. Genestie, S. Gouy, A. Oaknin, 2024, Journal for immunotherapy of cancer.

Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy

A. Guillot, Xiu-Juan Cai, Frank Tacke, 2024, bioRxiv.

Title: Multiomics analyses decipher intricate changes in the cellular and 1 metabolic landscape of steatotic livers upon dietary restriction and sleeve 2 gastrectomy

Hanyang Liu, A. Guillot, Shuai Chen, 2022 .

A novel transgenic mouse model highlights molecular disruptions involved in the pathogenesis of Dent disease 1.

F. Thévenod, S. Lourdel, Yohan Bignon, 2024, Gene.